GlassScriptPhysician profile
William S Waites
NPI 1992970297
$2,545.62
in general payments reported to CMS, 2019-2025
19 companies · $302 in 2025
The $302 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $710 · 2022: $667 · 2023: $493 · 2024: $374 · 2025: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,169.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $692.78 | 2021-2025 | Belbuca |
| Abbvie INC. | $664.73 | 2021-2025 | |
| Biohaven Pharmaceuticals, INC. | $397.84 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $231.79 | 2022 | |
| Alnylam Pharmaceuticals INC. | $147.02 | 2022-2025 | Oxlumo |
| Amgen INC. | $85.73 | 2021-2022 | |
| Stimwave Technologies Incorporated | $47.72 | 2021 | |
| Redhill Biopharma INC. | $41.92 | 2021 | |
| Biodelivery Sciences International, INC. | $34.08 | 2021 | |
| Astellas Pharma US INC | $29.93 | 2023 | Veozah |
| Boston Scientific Corporation | $28.12 | 2022 | |
| Averitas Pharma INC. | $25.67 | 2023 | Qutenza |
| Indivior INC. | $22.62 | 2023 | Sublocade |
| Hikma Pharmaceuticals USA | $21.00 | 2022 | |
| Pfizer INC. | $17.30 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $16.69 | 2023 | Senza |
| Otsuka America Pharmaceutical, INC. | $16.11 | 2023 | Rexulti |
| Lundbeck LLC | $12.73 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Waites listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.